| Heading: |
Medicines and Healthcare products Regulatory Agency: Artificial Intelligence |
| Question ID: |
1759243 |
| UIN: |
26791 |
| House: |
Commons |
| Date tabled: |
2025-01-28 |
| Asking Member ID: |
350 |
| Asking Member display name: |
Sir John Hayes
|
| Asking Member handle: |
|
| Asking Member Twitter reference: |
Sir John Hayes
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, for what purposes the Medicines and Healthcare products Regulatory Agency has used artificial intelligence in the last 12 months. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-02-03 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4444 |
| Answering Member display name: |
Karin Smyth
|
| Answering Member handle: |
karinsmyth
|
| Answering Member Twitter reference: |
@karinsmyth
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
During 2024, the Medicines and Healthcare products Regulatory Agency (MHRA) identified 20 artificial intelligence (AI) use-cases for prototyping with different technologies with different AI paradigms.The use-cases range from productivity through to decis... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |